Specific and distinct determinants mediate membrane binding and lipid raft incorporation of HIV-1SF2 Nef

Virology

Volumn 355, Issue 2, 2006, Pages 175-191

  Giese, Simone I ^a   Woerz, Ilka ^a   Homann, Stefanie ^a   Tibroni, Nadine ^a   Geyer, Matthias ^b   Fackler, Oliver T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Cell surface receptor modulation; HIV Nef; Membrane association; Raft incorporation; Virion incorporation; Virus infectivity and replication

Indexed keywords

ARGININE; CELL SURFACE RECEPTOR; LYSINE; NEF PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LIPID RAFT; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LOCALIZATION; T LYMPHOCYTE; VIRION; VIRUS REPLICATION;

AMINO ACID MOTIFS; ARTIFICIAL GENE FUSION; BLOTTING, WESTERN; CELL FRACTIONATION; CELL LINE; CELL MEMBRANE; CELLS, CULTURED; GENE PRODUCTS, NEF; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; MEMBRANE MICRODOMAINS; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; PROTEIN BINDING; PROTEIN SORTING SIGNALS; PROTEIN STRUCTURE, TERTIARY; PROTEIN-SERINE-THREONINE KINASES; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33750614324     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.07.003     Document Type: Article

References (71)

1. Aiken C., and Trono D. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69 (1995) 5048-5056
2. Aiken C., Konner J., Landau N.R., Lenburg M.E., and Trono D. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76 (1994) 853-864
3. Aiken C., Krause L., Chen Y.L., and Trono D. Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology 217 (1996) 293-300
4. Alexander M., Bor Y.C., Ravichandran K.S., Hammarskjold M.L., and Rekosh D. Human immunodeficiency virus type 1 Nef associates with lipid rafts to downmodulate cell surface CD4 and class I major histocompatibility complex expression and to increase viral infectivity. J. Virol. 78 (2004) 1685-1696
5. Alland L., Peseckis S.M., Atherton R.E., Berthiaume L., and Resh M.D. Dual myristoylation and palmitoylation of Src family member p59fyn affects subcellular localization. J. Biol. Chem. 269 (1994) 16701-16705
6. Arora V.K., Molina R.P., Foster J.L., Blakemore J.L., Chernoff J., Fredericksen B.L., and Garcia J.V. Lentivirus Nef specifically activates Pak2. J. Virol. 74 (2000) 11081-11087
7. Arora V.K., Fredericksen B.L., and Garcia J.V. Nef: agent of cell subversion. Microbes Infect. 4 (2002) 189-199
8. Baur A.S., Sawai E.T., Dazin P., Fantl W.J., Cheng-Mayer C., and Peterlin B.M. HIV-1 Nef leads to inhibition or activation of T cells depending on its intracellular localization. Immunity 1 (1994) 373-384
9. Baur A.S., Sass G., Laffert B., Willbold D., Cheng-Mayer C., and Peterlin B.M. The N-terminus of Nef from HIV-1/SIV associates with a protein complex containing Lck and a serine kinase. Immunity 6 (1997) 283-291
10. Benson R.E., Sanfridson A., Ottinger J.S., Doyle C., and Cullen B.R. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J. Exp. Med. 177 (1993) 1561-1566
11. Bentham M., Mazaleyrat S., and Harris M. The di-leucine motif in the cytoplasmic tail of CD4 is not required for binding to human immunodeficiency virus type 1 Nef, but is critical for CD4 down-modulation. J. Gen. Virol. 84 (2003) 2705-2713
12. Bentham M., Mazaleyrat S., and Harris M. Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J. Gen. Virol. 87 (2006) 563-571
13. Blagoveshchenskaya A.D., Thomas L., Feliciangeli S.F., Hung C.H., and Thomas G. HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 111 (2002) 853-866
14. Breuer S., Gerlach H., Kolaric B., Urbanke C., Opitz N., and Geyer M. Biochemical indication for myristoylation-dependent conformational changes in HIV-1 Nef. Biochemistry 45 (2006) 2339-2349
15. Brugger B., Glass B., Haberkant P., Leibrecht I., Wieland F.T., and Krausslich H.G. The HIV lipidome: A raft with an unusual composition. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 2641-2646
16. Casartelli N., Di Matteo G., Argentini C., Cancrini C., Bernardi S., Castelli G., Scarlatti G., Plebani A., Rossi P., and Doria M. Structural defects and variations in the HIV-1 nef gene from rapid, slow and non-progressor children. Aids 17 (2003) 1291-1301
17. Coates K., Cooke S.J., Mann D.A., and Harris M.P. Protein kinase C-mediated phosphorylation of HIV-I nef in human cell lines. J. Biol. Chem. 272 (1997) 12289-12294
18. Collins K.L., Chen B.K., Kalams S.A., Walker B.D., and Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391 (1998) 397-401
19. Costa L.J., Zheng Y.H., Sabotic J., Mak J., Fackler O.T., and Peterlin B.M. Nef binds p6* in GagPol during replication of human immunodeficiency virus type 1. J. Virol. 78 (2004) 5311-5323
20. Craig H.M., Reddy T.R., Riggs N.L., Dao P.P., and Guatelli J.C. Interactions of HIV-1 nef with the mu subunits of adaptor protein complexes 1, 2, and 3: role of the dileucine-based sorting motif. Virology 271 (2000) 9-17
21. Fackler O.T., Kienzle N., Kremmer E., Boese A., Schramm B., Klimkait T., Kucherer C., and Mueller-Lantzsch N. Association of human immunodeficiency virus Nef protein with actin is myristoylation dependent and influences its subcellular localization. Eur. J. Biochem. 247 (1997) 843-851
22. Fackler O.T., Lu X., Frost J.A., Geyer M., Jiang B., Luo W., Abo A., Alberts A.S., and Peterlin B.M. p21-activated kinase 1 plays a critical role in cellular activation by Nef. Mol. Cell. Biol. 20 (2000) 2619-2627
23. Fackler O.T., Wolf D., Weber H.O., Laffert B., D'Aloja P., Schuler-Thurner B., Geffin R., Saksela K., Geyer M., Peterlin B.M., Schuler G., and Baur A.S. A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells. Curr. Biol. 11 (2001) 1294-1299
24. Fackler O., Moris A., Tibroni N., Giese S., Glass B., Schwartz O., and Kräusslich H.G. Functional characterization of HIV-1 Nef mutants in the context of viral infection. Virology 351 (2006) 332-339
25. Fortin J.F., Barat C., Beausejour Y., Barbeau B., and Tremblay M.J. Hyper-responsiveness to stimulation of human immunodeficiency virus-infected CD4+ T cells requires Nef and Tat virus gene products and results from higher NFAT, NF-kappaB, and AP-1 induction. J. Biol. Chem. 279 (2004) 39520-39531
26. Galbiati F., Volonte D., Meani D., Milligan G., Lublin D.M., Lisanti M.P., and Parenti M. The dually acylated NH2-terminal domain of gi1alpha is sufficient to target a green fluorescent protein reporter to caveolin-enriched plasma membrane domains. Palmitoylation of caveolin-1 is required for the recognition of dually acylated g-protein alpha subunits in vivo. J. Biol. Chem. 274 (1999) 5843-5850
27. Garcia J.V., and Miller A.D. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350 (1991) 508-511
28. Geyer M., and Peterlin B.M. Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef. FEBS Lett. 496 (2001) 91-95
29. Geyer M., Munte C.E., Schorr J., Kellner R., and Kalbitzer H.R. Structure of the anchor-domain of myristoylated and non-myristoylated HIV-1 Nef protein. J. Mol. Biol. 289 (1999) 123-138
30. Geyer M., Fackler O.T., and Peterlin B.M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2 (2001) 580-585
31. Greenberg M.E., Bronson S., Lock M., Neumann M., Pavlakis G.N., and Skowronski J. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. EMBO J. 16 (1997) 6964-6976
32. Iafrate A.J., Bronson S., and Skowronski J. Separable functions of Nef disrupt two aspects of T cell receptor machinery: CD4 expression and CD3 signaling. EMBO J. 16 (1997) 673-684
33. Kaminchik J., Margalit R., Yaish S., Drummer H., Amit B., Sarver N., Gorecki M., and Panet A. Cellular distribution of HIV type 1 Nef protein: identification of domains in Nef required for association with membrane and detergent-insoluble cellular matrix. AIDS Res. Hum. Retroviruses 10 (1994) 1003-1010
34. Keppler O.T., Allespach I., Schuller L., Fenard D., Greene W.C., and Fackler O.T. Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef. J. Virol. 79 (2005) 1655-1665
35. Keppler O.T., Tibroni N., Venzke S., Rauch S., and Fackler O.T. Modulation of specific surface receptors and activation sensitization in primary resting CD4+ T lymphocytes by the Nef protein of HIV-1. J. Leukocyte Biol. 79 (2006) 616-627
36. Krautkramer E., Giese S.I., Gasteier J.E., Muranyi W., and Fackler O.T. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 78 (2004) 4085-4097
37. Lama J. The physiological relevance of CD4 receptor down-modulation during HIV infection. Curr. HIV Res. 1 (2003) 167-184
38. Liang X., Lu Y., Wilkes M., Neubert T.A., and Resh M.D. The N-terminal SH4 region of the Src family kinase Fyn is modified by methylation and heterogeneous fatty acylation: role in membrane targeting, cell adhesion, and spreading. J. Biol. Chem. 279 (2004) 8133-8139
39. Mangasarian A., Piguet V., Wang J.K., Chen Y.L., and Trono D. Nef-induced CD4 and major histocompatibility complex class I (MHC-I) down-regulation are governed by distinct determinants: N-terminal alpha helix and proline repeat of Nef selectively regulate MHC-I trafficking. J. Virol. 73 (1999) 1964-1973
40. McCabe J.B., and Berthiaume L.G. Functional roles for fatty acylated amino-terminal domains in subcellular localization. Mol. Biol. Cell 10 (1999) 3771-3786
41. McCabe J.B., and Berthiaume L.G. N-terminal protein acylation confers localization to cholesterol, sphingolipid-enriched membranes but not to lipid rafts/caveolae. Mol. Biol. Cell 12 (2001) 3601-3617
42. Michel N., Allespach I., Venzke S., Fackler O.T., and Keppler O.T. The Nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4. Curr. Biol. 15 (2005) 714-723
43. Michel N., Ganter K., Venzke S., Bitzegeio J., Fackler O.T., and Keppler O.T. The Nef protein of human immunodeficiency virus is a broad-spectrum modulator of chemokine receptor cell surface levels that acts independently of classical motifs for receptor endocytosis and G{α}i-signaling. Mol. Biol. Cell 17 (2006) 3578-3590
44. Muller B., Daecke J., Fackler O.T., Dittmar M.T., Zentgraf H., and Krausslich H.G. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. J. Virol. 78 (2004) 10803-10813
45. Niederman T.M., Hastings W.R., and Ratner L. Myristoylation-enhanced binding of the HIV-1 Nef protein to T cell skeletal matrix. Virology 197 (1993) 420-425
46. Piguet V., Wan L., Borel C., Mangasarian A., Demaurex N., Thomas G., and Trono D. HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes. Nat. Cell Biol. 2 (2000) 163-167
47. Pulkkinen K., Renkema G.H., Kirchhoff F., and Saksela K. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J. Virol. 78 (2004) 12773-12780
48. Qiao X., He B., Chiu A., Knowles D.M., Chadburn A., and Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 7 (2006) 302-310
49. Raney A., Kuo L.S., Baugh L.L., Foster J.L., and Garcia J.V. Reconstitution and molecular analysis of an active human immunodeficiency virus type 1 Nef/p21-activated kinase 2 complex. J. Virol. 79 (2005) 12732-12741
50. Renkema G.H., Manninen A., Mann D.A., Harris M., and Saksela K. Identification of the Nef-associated kinase as p21-activated kinase 2. Curr. Biol. 9 (1999) 1407-1410
51. Resh M.D. Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins. Biochim. Biophys. Acta 1451 (1999) 1-16
52. Resh M.D. Membrane targeting of lipid modified signal transduction proteins. Subcell. Biochem. 37 (2004) 217-232
53. Roeth J.F., Williams M., Kasper M.R., Filzen T.M., and Collins K.L. HIV-1 Nef disrupts MHC-I trafficking by recruiting AP-1 to the MHC-I cytoplasmic tail. J. Cell Biol. 167 (2004) 903-913
54. Rose J.J., Janvier K., Chandrasekhar S., Sekaly R.P., Bonifacino J.S., and Venkatesan S. CD4 down-regulation by HIV-1 and simian immunodeficiency virus (SIV) Nef proteins involves both internalization and intracellular retention mechanisms. J. Biol. Chem. 280 (2005) 7413-7426
55. Saksela K. Therapeutic targeting of interactions between Nef and host cell proteins. Curr. Drug Targets Immune Endocr. Metabol. Disord. 4 (2004) 315-319
56. Sawai E.T., Baur A., Struble H., Peterlin B.M., Levy J.A., and Cheng-Mayer C. Human immunodeficiency virus type 1 Nef associates with a cellular serine kinase in T lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1539-1543
57. Schindler M., Wurfl S., Benaroch P., Greenough T.C., Daniels R., Easterbrook P., Brenner M., Munch J., and Kirchhoff F. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles. J. Virol. 77 (2003) 10548-10556
58. Schwartz O., Marechal V., Danos O., and Heard J.M. Human immunodeficiency virus type 1 Nef increases the efficiency of reverse transcription in the infected cell. J. Virol. 69 (1995) 4053-4059
59. Schwartz O., Marechal V., Le Gall S., Lemonnier F., and Heard J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 2 (1996) 338-342
60. Sol-Foulon N., Esnault C., Percherancier Y., Porrot F., Metais-Cunha P., Bachelerie F., and Schwartz O. The effects of HIV-1 Nef on CD4 surface expression and viral infectivity in lymphoid cells are independent of rafts. J. Biol. Chem. 279 (2004) 31398-31408
61. Stumptner-Cuvelette P., Morchoisne S., Dugast M., Le Gall S., Raposo G., Schwartz O., and Benaroch P. HIV-1 Nef impairs MHC class II antigen presentation and surface expression. Proc. Natl. Acad. Sci. U.S.A. 98 (2001) 12144-12149
62. Stumptner-Cuvelette P., Jouve M., Helft J., Dugast M., Glouzman A.S., Jooss K., Raposo G., and Benaroch P. Human immunodeficiency virus-1 Nef expression induces intracellular accumulation of multivesicular bodies and major histocompatibility complex class II complexes: potential role of phosphatidylinositol 3-kinase. Mol. Biol. Cell 14 (2003) 4857-4870
63. Tolstrup M., Ostergaard L., Laursen A.L., Pedersen S.F., and Duch M. HIV/SIV escape from immune surveillance: focus on Nef. Curr. HIV Res. 2 (2004) 141-151
64. Tritel M., and Resh M.D. Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates. J. Virol. 74 (2000) 5845-5855
65. Wang J.K., Kiyokawa E., Verdin E., and Trono D. The Nef protein of HIV-1 associates with rafts and primes T cells for activation. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 394-399
66. Welker R., Harris M., Cardel B., and Krausslich H.G. Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J. Virol. 72 (1998) 8833-8840
67. Williams M., Roeth J.F., Kasper M.R., Filzen T.M., and Collins K.L. Human immunodeficiency virus type 1 Nef domains required for disruption of major histocompatibility complex class I trafficking are also necessary for coprecipitation of Nef with HLA-A2. J. Virol. 79 (2005) 632-636
68. Wimley W.C., and White S.H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3 (1996) 842-848
69. Wolf D., Witte V., Laffert B., Blume K., Stromer E., Trapp S., d'Aloja P., Schurmann A., and Baur A.S. HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat. Med. 7 (2001) 1217-1224
70. Xu X.N., Laffert B., Screaton G.R., Kraft M., Wolf D., Kolanus W., Mongkolsapay J., McMichael A.J., and Baur A.S. Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J. Exp. Med. 189 (1999) 1489-1496
71. Zheng Y.H., Plemenitas A., Linnemann T., Fackler O.T., and Peterlin B.M. Nef increases infectivity of HIV via lipid rafts. Curr. Biol. 11 (2001) 875-879